MD1009Z - Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma - Google Patents
Method for determining the susceptibility of a person to the development of non-Hodgkin lymphomaInfo
- Publication number
- MD1009Z MD1009Z MDS20150029A MDS20150029A MD1009Z MD 1009 Z MD1009 Z MD 1009Z MD S20150029 A MDS20150029 A MD S20150029A MD S20150029 A MDS20150029 A MD S20150029A MD 1009 Z MD1009 Z MD 1009Z
- Authority
- MD
- Moldova
- Prior art keywords
- susceptibility
- person
- development
- hodgkin lymphoma
- determining
- Prior art date
Links
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 108020004705 Codon Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 abstract 1
- 101150042435 Xrcc1 gene Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 229940072221 immunoglobulins Drugs 0.000 abstract 1
Abstract
The invention relates to medicine, in particular to hematology and can be used for determining the susceptibility of a person to the development of non-Hodgkin lymphoma.According to the invention, the method consists in the fact that persons in whom is determined the Arg/Arg genotype of the XRCC1 gene codon is additionally determined the ratio of IgM and IgG immunoglobulins and where the ratio is 0.03…0.24, it is established the person's susceptibility to the development of non-Hodgkin lymphoma.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20150029A MD1009Z (en) | 2015-03-02 | 2015-03-02 | Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20150029A MD1009Z (en) | 2015-03-02 | 2015-03-02 | Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma |
Publications (2)
Publication Number | Publication Date |
---|---|
MD1009Y MD1009Y (en) | 2016-02-29 |
MD1009Z true MD1009Z (en) | 2016-09-30 |
Family
ID=55447203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDS20150029A MD1009Z (en) | 2015-03-02 | 2015-03-02 | Method for determining the susceptibility of a person to the development of non-Hodgkin lymphoma |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD1009Z (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD280C2 (en) * | 1993-03-17 | 1996-01-31 | Онкологический Институт Республики Молдова | Method of treatment of upper extremity lymphostase and the device for its achievement |
MD1367C2 (en) * | 1992-11-13 | 2000-11-30 | Idec Pharmaceuticals Corporation | Methods of B-cells lymphoma treatment, anti-CD20 antibodies, hybridoma |
RU2211695C2 (en) * | 2001-10-08 | 2003-09-10 | Ростовский научно-исследовательский онкологический институт | Method for treating non-hodgkin's lymphomas |
RU2007115763A (en) * | 2007-04-25 | 2008-10-27 | Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) (RU) | METHOD FOR FORECASTING THE EFFECTIVENESS OF LYMPH THERAPY |
RU2373862C1 (en) * | 2008-04-07 | 2009-11-27 | Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) | Method of determining person's predisposaition to development of aggressive non-hodgkin's lymphomas |
RU2490641C1 (en) * | 2012-08-01 | 2013-08-20 | Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" | Method for prediction of clinical course of non-hodgkin lymphomas |
RU2490638C1 (en) * | 2012-08-01 | 2013-08-20 | Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" | Method for prediction of developing b cell and t cell non-hodgkin lymphomas |
RU2012108895A (en) * | 2012-03-07 | 2013-11-20 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации | METHOD FOR FORECASTING THE COURSE OF MALIGNANT LYMPHOMAS |
-
2015
- 2015-03-02 MD MDS20150029A patent/MD1009Z/en not_active IP Right Cessation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD1367C2 (en) * | 1992-11-13 | 2000-11-30 | Idec Pharmaceuticals Corporation | Methods of B-cells lymphoma treatment, anti-CD20 antibodies, hybridoma |
MD280C2 (en) * | 1993-03-17 | 1996-01-31 | Онкологический Институт Республики Молдова | Method of treatment of upper extremity lymphostase and the device for its achievement |
RU2211695C2 (en) * | 2001-10-08 | 2003-09-10 | Ростовский научно-исследовательский онкологический институт | Method for treating non-hodgkin's lymphomas |
RU2007115763A (en) * | 2007-04-25 | 2008-10-27 | Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) (RU) | METHOD FOR FORECASTING THE EFFECTIVENESS OF LYMPH THERAPY |
RU2373862C1 (en) * | 2008-04-07 | 2009-11-27 | Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) | Method of determining person's predisposaition to development of aggressive non-hodgkin's lymphomas |
RU2012108895A (en) * | 2012-03-07 | 2013-11-20 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации | METHOD FOR FORECASTING THE COURSE OF MALIGNANT LYMPHOMAS |
RU2490641C1 (en) * | 2012-08-01 | 2013-08-20 | Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" | Method for prediction of clinical course of non-hodgkin lymphomas |
RU2490638C1 (en) * | 2012-08-01 | 2013-08-20 | Федеральное бюджетное учреждение науки "Уфимский научно-исследовательский институт медицины труда и экологии человека" | Method for prediction of developing b cell and t cell non-hodgkin lymphomas |
Also Published As
Publication number | Publication date |
---|---|
MD1009Y (en) | 2016-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ753515A (en) | Methods for treatment of cancer comprising tigit-binding agents | |
SV2018005678A (en) | ANTIBODY THAT NEUTRALIZES THE HUMAN SYNTHETIC RESPIRATORY VIRUS | |
MX2023000781A (en) | Humanized, mouse or chimeric anti-cd47 monoclonal antibodies. | |
SG11201906780SA (en) | Bcma-targeting antibody and use thereof | |
NZ738008A (en) | Tigit-binding agents and uses thereof | |
PH12018500707A1 (en) | Anti-human cd19 antibodies with high affinity | |
NZ741129A (en) | Anti-pd1 antibodies and methods of use | |
NZ739252A (en) | Monoclonal antibodies against bcma | |
TN2016000559A1 (en) | Monoclonal antibodies against her2 epitope and methods of use thereof | |
NZ739750A (en) | Anti-tigit antibodies and methods of use | |
EA201992546A1 (en) | MEANS ON THE BASIS OF ANTIBODIES TO CD33 | |
CY1122456T1 (en) | MONOCLONAL ANTIBODIES AGAINST GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15), AND USES THEREOF FOR THE THERAPEUTIC TREATMENT OF CANCER CACHESIS AND CANCER | |
WO2016100985A3 (en) | Chimeric antigen receptors and methods of use thereof | |
MA40576B1 (en) | Anti-her2 antibodies and immunoconjugates | |
MY197441A (en) | Antibodies targeting fc receptor-like 5 and method of use | |
UA120948C2 (en) | New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs | |
MX2017016169A (en) | Anti-her2 antibodies and methods of use. | |
MX2013009679A (en) | Anti-il-6 receptor antibodies and methods of use. | |
PH12018500887A1 (en) | Anti-htra1 antibodies and methods of use thereof | |
MX370191B (en) | Compositions and methods for the treatment of immunodeficiency. | |
MA39248B1 (en) | Anti-jagged1 antibodies and methods of use thereof | |
NZ741067A (en) | Bispecific anti-human cd20/human transferrin receptor antibodies and methods of use | |
EP3411504A4 (en) | Anti-tnf antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes | |
FI3615066T3 (en) | Formulations of human anti-rankl antibodies, and methods of using the same | |
TN2013000472A1 (en) | Induction of immune tolerance by using methotrexate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG9Y | Short term patent issued | ||
KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |